Coliseum Capital Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.8M Hold
13,100,807
3.86% 8
2026
Q1
$29.9M Hold
13,100,807
2.45% 11
2025
Q4
$36.7M Hold
13,100,807
3.01% 10
2025
Q3
$62.9M Buy
13,100,807
+1,537,852
+13% +$9.78M 6.14% 8
2025
Q2
$105M Buy
11,562,955
+938,356
+9% +$6.92M 7.55% 4
2025
Q1
$95.9M Buy
10,624,599
+5,838,635
+122% +$61.6M 8.01% 5
2024
Q4
$62.6M Buy
4,785,964
+1,141,483
+31% +$15.2M 5.16% 9
2024
Q3
$57.2M Buy
+3,644,481
New +$55.2M 5.53% 7

Other funds holding ACH

Coliseum Capital Management's ACH Position: Q2 2026 in Review

Coliseum Capital Management held its Accendra Health (ACH) position steady in Q2 2026 at 13,100,807 shares worth $44.8M. The position accounts for 3.86% of the portfolio, ranked #8.

Coliseum Capital Management first reported a position in ACH in Q3 2024 and has held it in 8 quarters since. The position peaked at $105M in Q2 2025. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Coliseum Capital Management held 13,100,807 shares of Accendra Health worth $44.8M as of Q2 2026.
  • Coliseum Capital Management left its Accendra Health share count unchanged in Q2 2026.
  • Accendra Health made up 3.86% of Coliseum Capital Management's portfolio in Q2 2026, its #8 holding.
  • Coliseum Capital Management first reported a position in Accendra Health in Q3 2024 and has held it in 8 quarters since.
  • Coliseum Capital Management's Accendra Health position peaked at $105M in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Coliseum Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.